Prostate cancer continues to be the most commonly diagnosed cancer, and the second leading cause of cancer death among Australian men. Prostate-specific antigen testing is personalised (not dichotomous in nature) and its interpretation should take into account the patient’s age, symptoms, previous results and medication (eg, 5-α reductase inhibitors such as dutasteride).